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IARC Carcinogen Update
We recently published an article in which we
presented a list of occupational carcinogens
(Siemiatycki et al. 2004), based on the
International Agency for Research on Cancer
(IARC) Monographs Program. Our review
covered Volumes 1–83 of the IARC
Monographs. However, because the IARC
Monograph Program is ongoing, the list of
occupational carcinogens will need to be
periodically updated. Since we completed our
article, there have been three Monograph
meetings that addressed substances that can
be classified as occupational; therefore, we
would like to notify readers of some impor-
tant changes in the list of occupational car-
cinogens. Table 1 shows summary
information about occupational substances
and mixtures that were recently evaluated by
IARC as human carcinogens (group 1), prob-
able human carcinogens (group 2A), or possi-
ble human carcinogens (group 2B). As we
did in our earlier article (Siemiatycki et al.
2004), we added to the IARC evaluations
our assessment of the main occupations in
which the agent may be found and the target
organ for carcinogenicity. 
Volume 86 focuses on cobalt in hard-
metals and cobalt sulfate, gallium arsenide,
indium phosphide, and vanadium pentoxide
(IARC, in press a) In our article (Siemiatycki
et al. 2004), cobalt and cobalt compounds
were listed as Group 2B human carcinogens.
In IARC’s recent evaluation (IARC, in
press a), cobalt metal with tungsten carbide
is classified in Group 2A, whereas cobalt
metal without tungsten carbide, cobalt sul-
fate, and other soluble cobalt(II) salts
remain in Group 2B. Three substances for
which there were no previous IARC evalu-
ations have now been evaluated and classi-
fied: gallium arsenide is classified as a
Group 1 human carcinogen, indium phos-
phide as a Group 2A (probable) human
carcinogen, and vanadium pentoxide as a
Group 2B (possible) human carcinogen
(IARC, in press a).
Volume 87 (IARC, in press b) updates
the prior evaluations on inorganic and
organic lead compounds, which were
included in Volume 23 (IARC 1980) and
in Supplement 7 (IARC 1987). Previously,
lead and inorganic lead compounds were
classified in Group 2B, whereas organic lead
compounds were classified in Group 3. The
most recent IARC evaluation results in an
upgrading of inorganic lead compounds to
Group 2A; organic lead compounds remain
in Group 3 (IARC, in press b). The
Working Group, however, noted that part
of the organic lead is metabolized into ionic
lead, which would be expected to present
the same toxicity as inorganic lead.
In Volume 88, formaldehyde was
upgraded from a Group 2A (probable) to a
Group 1 human carcinogen (IARC, in
press c; Cogliano et al. 2005). The other
two substances covered by this monograph,
2-butoxyethanol and 1-tert-butoxy-2-
propanol, are evaluated as Group 3 (not
classifiable).
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Table 1. Substances and mixtures that have been evaluated by IARC as human carcinogens and that are occupational exposures, based on Monograph Volumes 84–90.
IARC IARC
Substance or mixture Occupation or industry in which the substance is founda Site(s) classification Monograph
Cobalt metal with tungsten carbide  Production of cemented carbides (hard-metal industry);  Lungb  2A 86
tool grinders; saw filers; diamond polishers
Cobalt metal without tungsten carbide  Miners; production of alloys; processing of copper  Uncertain 2B 86
and nickel ore; glass and ceramic production; 
welders of cobalt-containing alloys
Cobalt sulfate and other soluble cobalt(II) salts Electroplating and ceramic industries  Uncertain 2B 86
Gallium arsenide  Production; microelectronics industry (integrated  Uncertain 1c 86
circuits and optoelectronic devices)
Indium phosphide  Production; microelectronics industry (integrated  Uncertain 2Ad 86
circuits and optoelectronic devices)
Vanadium pentoxide  Ore refining and processing; chemical manufacturing  Uncertain 2B 86
industry; maintenance of oil-fired boilers and furnaces
Inorganic lead compounds  Lead smelters; plumbers; solderers; occupations in  Lungb 2A 87
battery recycling smelters; production of lead-acid Stomachb
batteries; printing press occupations; pigment production; 
construction and demolition
Formaldehyde Production; pathologists; medical laboratory technicians;  Nasopharynxe 18 8
plastics; textile and plywood industry Leukemiab
Nasal sinusesb
aNot necessarily an exhaustive list of occupations/industries in which this agent is found; not all workers in these occupations/industries are exposed. The term “production” is used to
indicate that this substance is man-made and that workers may be exposed in the production process. bWe judged that the evidence for an association with this site was suggestive. cIn
reaching an overall evaluation of Group 1, the working group noted the potential for gallium arsenide to cause cancer through releases of a small amount of its arsenic, which behaves
as inorganic arsenic at the sites where it is distributed. Arsenic and arsenic compounds have been evaluated as IARC Group 1, carcinogenic to humans. For arsenic in drinking water,
the most recent IARC evaluation of arsenic [Volume 84; (IARC 2004)], there was sufficient evidence in humans that arsenic causes cancers of the urinary bladder, lung, and skin; the evi-
dence for cancers of the liver and kidney was limited. dAbsence of data on cancer in humans; the final evaluation for carcinogenicity was upgraded from 2B to 2A based on evidence of
carcinogenicity in experimental animals. eThe evidence was sufficient. Environmental Health Perspectives • VOLUME 113 | NUMBER 9 | September 2005 A 581
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Indoor- and Outdoor-Generated
Particles and Children with
Asthma
In their article “Pulmonary Effects of
Indoor- and Outdoor-Generated Particles in
Children with Asthma,” Koenig et al. (2005)
made use of their really interesting model
that enables them to discern exposure from
indoor- and outdoor-generated particles.
They concluded that 
The ambient-generated component of PM2.5
[particulate matter ≤ 2.5 µm in aerodynamic
diameter] exposure is consistently associated with
increases in eNO [exhaled nitric oxide] and the
indoor-generated component is less strongly asso-
ciated with eNO.
This finding should not lead to the
assumption that particles generated indoors
are in general not able to induce endogenous
NO production. The authors themselves
pointed out one limitation of their study: 
Children in the Seattle panel study spent an aver-
age of 66% of their time indoors at home and
21% indoors away from home (primarily at
school) … (Koenig et al. 2005)
However, contribution of indoor sources to
PM exposure was only estimated on the
basis of measurement data from the sub-
jects’ residences. This could have led to
uncertainties in the exposure assessment,
biasing the effect estimates toward null.
I also want to mention the great vari-
ability in possible indoor sources of PM. In
their article, Koenig et al. (2005) provided
no information on the smoking status of
household members. If the 19 children
under study lived in nonsmoking house-
holds, the results might be true for this set-
ting but not for others.
Finally, I suggest that time of measure-
ment and exposure should be considered. If
the children attend school in the morning,
they might go home (maybe in high traffic)
at noon or early afternoon for lunch. 
[NO] samples were collected in the afternoon or
early evening at the child’s residence. Children
were asked to forgo food intake for 1 hr before
collection of exhaled breath.
If NO production peaks several hours after
exposure, it could be possible that the chil-
dren’s exposure on their way home from
school was the most influential one (not
because of the origin of the particles but
because of the study’s lag structure). It
would be interesting and rather rewarding to
study the short-term lag structure between
PM exposure and both exhaled NO and
lung function [for which Koenig et al.
(2005) found an association with exposure
due to sources in the residents’ homes]. I
would expect an increase of exhaled NO to
be a rather late reaction to inflammatory
stimuli. For example Rolla et al. (2004)
reported that after aspirin inhalation by sub-
jects with aspirin-inducible asthma, NO
increased significantly reaching the peak
value 4 hr after bronchoconstriction.
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Indoor- and Outdoor-Generated
Particles: Koenig et al. Respond
We appreciate Moshammer’s comments
and his interest in our research. We have
several points to raise in reply. 
In our article (Koenig et al. 2005), we
stated that indoor sources are known to
affect airway inflammation. We recognized
that indoor sources vary greatly and that
19 homes may not provide a sufficient sam-
ple size to allow for a robust association. It is
true that the children in our study spent sub-
stantial time away from home. We now have
additional data from a panel of 16 adults
(average age of 75 years) who did not com-
mute or leave home regularly; in these adults
we found the same coefficient with eNO
(exhaled nitric oxide) versus outdoor PM2.5
(particulate matter ≤ 2.5 µm in aerodynamic
diameter) as in the research in question
(Jansen et al. 2004). In addition, Ebelt et al.
(2005) found lung function decrements only
with ambient particles in a group of non-
smoking 54- to 86-year-old adults. These
results provide additional evidence of an
ambient-only pulmonary effect among indi-
viduals who spent relatively little time away
from home. 
Regarding smoking status, one inclusion-
ary criterion for our study was to be a non-
smoker and live with nonsmokers; thus
smoking is not an important indoor source
of particles in these residences. Children in
the Seattle school district do not go home for
lunch. However, it is true that our exhaled
breath samples were taken 1–2 hr after the
commute home (Liu et al. 2003). On aver-
age, the time between morning commute
and eNO collection was 9 hr; between after-
noon commute and breath collection was
about 2 hr. We are now looking at the short-
term lag structure. Using a polynomial dis-
tributed lag model, we found that PM2.5 was
associated with the eNO for up to 10–12 hr
before the eNO measurement (Mar et al., in
press). 
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Blood Lead and IQ in Older
Children
In their article about blood lead and IQ in
older children, Chen et al. (2005) made the
very important observation that IQ (intelli-
gence quotient) in older children correlates
better with their current blood lead level
than with levels determined at 2 years of
age. This observation has enormous public
health implications in terms of defining who
is at risk of cognitive decrement upon expo-
sure to lead, and challenges the widely held
assumption that the effects of lead on neuro-
behavioral function are exclusively develop-
mental. My colleagues and I (Carpenter
et al. 2002) previously studied the effects of
gestational and lactational exposure of rats
to lead with measurement of long-term
potentiation in hippocampal brain slices.
Long-term potentiation is an electro-
physiological measure of synaptic plasticity
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that is widely viewed as being at least one
component of learning and memory, and it
is reduced upon in vivo lead exposure. To
our surprise we also found that acute perfu-
sion of low concentrations of lead onto
brain slices from control animals resulted in
reduction of long-term potentiation, sug-
gesting that the effect is more pharmacologic
than developmental. The results of Chen
et al. (2005) in humans and our studies in
rats suggest that lead causes both develop-
mental and pharmacologic impairment of
cognitive function. If this is true, then steps
should be taken to prevent exposure to lead
and to reduce lead levels in individuals of
any age, not just young children.
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not to do so.
Comparison of Study Controls
In the article “Natural Variability and the
Influence of Concurrent Control Values on
the Detection and Interpretation of Low-
Dose or Weak Endocrine Toxicities,” Ashby
et al. (2004) discounted a number of studies
reporting low-dose effects caused by
endocrine-disrupting chemicals, including
bisphenol A (BPA), based on variability in
control values in experiments conducted at
different times. They cited data from four
experiments that we reported in three pub-
lished studies (Ohsako et al. 2001; Sakaue
et al. 1999, 2001). Ashby et al. stated that
the marked reduction in daily sperm produc-
tion (DSP) caused by BPA that we observed
in two experiments (Sakaue et al. 2001)
should be discounted because the DSP val-
ues in BPA-exposed males were not signifi-
cantly different from those in controls we
reported in another study (Ohsako et al.
2001). Ashby et al. (2004) proposed that our
conclusion that BPA significantly decreased
DSP is incorrect because of a difference in
control values for DSP from different experi-
ments conducted at different times.
We would like to point out that it is
absolutely inappropriate to compare these
sets of data not only because the experiments
were conducted at different times but also
because they included different experimental
conditions and different animals (Table 1).
First, we used Sprague-Dawley rats in the
two experiments in the BPA study (Sakaue
et al. 2001) and Holtzman rats in another
study of 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) (Ohsako et al. 2001). Second, the
Sprague-Dawley rats used in the BPA study
were purchased from a laboratory animal
breeder, whereas the Holtzman rats used in
the TCDD experiment were bred at the
National Institute for Environmental Studies
(NIES). Third, animal maintenance condi-
tions were not the same for the three studies:
Holtzman rats were housed in polycarbonate
cages with wooden chips, and Sprague-
Dawley rats were kept in hanging stainless
wire-mesh cages. 
There are many reasons why males from
different rat strains obtained from different
breeding facilities using different animal feed
and housing conditions might differ in DSP.
We thus disagree with the interpretation by
Ashby et al. (2004) that this variability
between rats from different strains invalidates
the conclusion drawn by Sakaue et al.
(2001) that exposure to BPA reduces DSP in
Sprague-Dawley rats. We also disagree with
their attempt to discount effects caused by
BPA and other endocrine-disrupting chemi-
cals due to variability in control animals
from entirely different experiments in which
low-dose effects were reported by other
researchers.
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Study Controls: Ashby Responds
Figure 1 is the relevant summary figure
(Figure 8) from our article (Ashby et al.
2004). Our point in the article, as well as
now, is that it is incumbent upon each
investigator to accept, to study, and where
possible, to understand the extent, nature,
and origins of variability (within and
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Table 1. Comparison of conditions of the three experiments.
Sakaue et al. 1999 Ohsako et al. 2001 Sakaue et al. 2001
Rat strains Holtzman Holtzman Sprague Dawley
Place of birth Animal breeding facility (NIES) Chemical hazard area (NIES) CLEA Japan
Age at the time of purchase NA NA PND77
Cage type Stainless wire-mesh Polycarbonate plastic Stainless wire-mesh
Bedding None Wood  chip None
Age at the time of tissue collection PND126  PND120 PND126
Place for examination Animal breeding facility (NIES) Chemical hazard area (NIES) Animal breeding facility (NIES)
Test compound BPA TCDD BPA
Vehicle Corn oil Corn oil/4% n-nonane Corn oil/6.5% ethanol
Control DSP valuea 39.0 ± 1.6 (4) 34.6±2.0 (12) 44.0±2.2 (5)b
(× 106/testis) 49.3±5.3 (8)c
Abbreviations: NA, not applicable; PND, postnatal day.
aMean ± SE (number of animals). bFirst experiment. cSecond experiment.Environmental Health Perspectives • VOLUME 113 | NUMBER 9 | September 2005 A 583
between experiments) of the critical assay
parameter. If you do not know why the
assay parameter varies naturally with time,
or between experiments, it becomes difficult
to interpret small perturbations of the para-
meter induced in a chemical toxicity study.
This was the problem we faced when we
tried to explain our inability, over four
extensive studies (Ashby et al. 2003), to con-
firm the effects that Sakaue et al. (2001)
reported for bisphenol A (BPA). The con-
trol values for daily sperm production (DSP)
in Sprague-Dawley rats over our four experi-
ments (Figure 1) varied little, despite the use
of three different rodent diets and a variety
of physical test conditions (changes in bed-
ding and caging). We also noted (Ashby
et al. 2004) that Sakaue et al. reported simi-
lar control DSP values for Holtzman rats
(Sakaue et al. 1999) and Sprague-Dawley
rats (Sakaue et al. 2001; Figure 1). The most
interesting aspect of the data in Figure 1 is
the extent of variability in control DSP val-
ues reported by Sakaue et al. (2001) for their
two experiments on BPA in Sprague-
Dawley rats. It is important to understand
the origins of these variations in control
DSP values between similar experiments
before interpreting small chemically induced
perturbations in DSP values with confi-
dence. Equally, by paying attention to the
origins of control variability, we were able to
show that two chemicals we had previously
considered to be negative in the rodent
uterotrophic assay were, in fact, weakly posi-
tive (Ashby et al. 2004). Stable control val-
ues for an assay lead to the generation of
sound assay data.
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ERRATUM
In "Decrease in Anogenital Distance
among Male Infants with Prenatal
Phthalate Exposure" [Environ Health
Perspect 113:1056–1061 (2005)],
Shanna Swan’s affiliation was listed as
University of Rochester, Rochester,
Minnesota. The correct location is
Rochester, New York. 
EHP regrets the error.
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Figure 1. Comparison of control DSP (mean ± SD)
reported from the same laboratory [Ohsako et al.
(2001) and Sakaue et al. (1999, 2001)] and a different
laboratory (Ashby et al. 2003) with the greatest
effect induced by BPA (Sakaue et al. 2001). A range
of BPA doses was used in these experiments, and
only the dose that induced the greatest effect in
each experiment is shown: 20 µg/kg (Sakaue et al.
1999); 200 µg/kg (Sakaue et al. 2001); 200 mg/kg
(Ashby et al. 2003). The effect of BPA is not signifi-
cantly different from the control reported by Ohsako
et al. (2001; bar 2: one- or two-sided Student's t-test).
Sakaue et al. (1999) and Ohsako et al. (2001) used
Holtzman rats, and Sakaue et al. (2001) and Ashby
et al. (2003) used Sprague-Dawley rats. However,
the identical control DSP values for Holtzman rats
(Sakaue et al. 1999, bar 1) and Sprague-Dawley rats
(Sakaue et al. 2001; bar 3) indicate that rat strain is
not a key variable on control DSP values and that,
consequently, it is possible to compare data across
strains and experiments for that laboratory.
Reprinted from Ashby et al. (2004) with permission
from Environmental Health Perspectives. 
*Reported by Sakaue et al. (2001) as statistically different
from the concurrent control (bars 3 and 4).
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